Assessing the efficacy of immediate release methylphenidate, sustained release methylphenidate and modafanil for patients with primary brain tumours undergoing chemotherapy.

Trial Profile

Assessing the efficacy of immediate release methylphenidate, sustained release methylphenidate and modafanil for patients with primary brain tumours undergoing chemotherapy.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 06 Aug 2012

At a glance

  • Drugs Methylphenidate (Primary) ; Methylphenidate (Primary) ; Modafinil (Primary)
  • Indications Cognition disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 May 2011 Status changed from completed to discontinued.
    • 05 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Jan 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top